Promising psychosocial treatments for pain in MS

For some people with MS, medicines can provide complete relief from pain,but many pain sufferers do not achieve adequate pain relief by pharmacological means

Read the rest »

Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases.

Researchers in The Netherlands have studied 2 pregnant women with MS who use Natalizumab

Read the rest »

An Important Measure of Therapeutic Response in MS

A study published in the Lancet Neurology this month assessed the efficacy and safety of cladribine for RRMS

Read the rest »

A Substantial Advance In The Treatment of Multiple Sclerosis

Now it seems that every day we inch nearer to improved management of MS and hopefully towards a cure.

This month a paper has been published which shows “a substantial advance in the treatment of multiple sclerosis”

Read the rest »

Prevention of EAE by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.

This study examined the long term effects of the opioid growth factor (OGF, [Met(5)]-enkephalin) and a low dose of the opioid blocker naltrexone (LDN) on induced EAE

Read the rest »

Pseudobulbar affect – affects 10% of people with MS

Pseudobulbar affect (PBA) is a neurologic condition that causes sudden, frequent, and involuntary episodes of crying or laughing.

Read the rest »

Could Early Symptoms of MS Be Stratified to Give Better Targeted Multiple Sclerosis Treatments?

To date MS has been unpredictable right from disease onset but , knowing the disease course is of crucial importance in guiding treatment.

Read the rest »



797
SPAM KILLED
BY WP-SPAMFREE